LPL loss-of-function variants used to model context-dependent clinical interpretation beyond current ACMG guidelines

Current clinical variant interpretation frameworks, including the widely used ACMG/AMP guidelines, assign a single pathogenicity classification to each variant irrespective of whether it is present in a homozygous, heterozygous, or compound-heterozygous state. A preprint posted to bioRxiv on 17 August 2026 argues that this approach fails to communicate clinically important context-dependent consequences.

The researchers use loss-of-function variants in LPL — the gene encoding lipoprotein lipase — as a model system. Heterozygous LPL loss-of-function variants are associated with modestly elevated triglycerides and a predisposition to cardiovascular risk, whereas biallelic loss causes severe familial hyperchylomicronaemia, a clinically distinct condition. The authors contend that collapsing these contexts into a single classification obscures meaningful biological and clinical differences.

The preprint proposes a proof-of-concept framework for context-dependent variant interpretation intended to accommodate inheritance state, zygosity, and broader genetic background. The authors position this as relevant not only to rare Mendelian disease diagnostics but also to emerging population screening programmes, where the same variant may carry different implications depending on how it is identified.

The work has not yet been peer-reviewed. Genetic counsellors and researchers working on variant classification frameworks are the primary audience for this methodological discussion.